Impending economic evolution in the rare disease landscape
Methods to increase orphan drug speed to market at a lower price to the patient
Strategies for pricing and cost saving valuation of orphan drugs
Factors affecting reimbursement and formulary decisions
Issues from a Tufts Center for the Study of Drug Development Impact Report
Findings on global orphan drug patient
Who should Attend
Senior attendees from:
Market access and commercialization from biotech and pharmaceutical companies within divisions of genetic, rare and orphan diseases
Pricing
Regulatory
Reimbursement
Health Economics
Marketing
Policy
Outcomes Research
Medical Directors
P&T Committees
Orphan Foundations/Associations
Business Development
Contract Research Organizations
Product launch
Advocacy Groups
Medical and Pharmacy Payers
Academia
Past Events
Rare Disease Economics and Orphan Drug Commercialization Summit 2014 - 22-23 Sep 2014, Hilton Boston Back Bay, Massachusetts, United States (46984)
Important
Please, check "Rare Disease Economics and Orphan Drug Commercialization Summit" official website for possible changes, before making any traveling arrangements
